Podcasts about Hepatitis B

On today's Flyover Conservatives Show, we sit down with Dr. Troy Spurrill to discuss the health stories raising major questions across America — from sleep, stress, and HRV to RFK Jr.'s comments on vaccines, autism, and the Hepatitis B shot, plus the shocking report of an NIH Ebola expert allegedly caught smuggling dangerous pathogens. Dr. Spurrill breaks down why so many healthcare workers are frustrated with the current system, what functional medicine looks like, how parents can ask better questions, and why sleep may be one of the most overlooked keys to healing. This conversation covers medical freedom, Big Pharma, RFK Jr., gain-of-function concerns, sleep tracking, REM sleep, deep sleep, and the growing movement to restore common sense, clean data, and personal responsibility in healthcare.TO WATCH ALL FLYOVER CONTENT: www.theflyoverapp.com Follow and Subscribe on YouTube: https://www.youtube.com/@TheFlyoverConservativesShow To Schedule A Time To Talk To Dr. Dr. Kirk Elliott Go To ▶ https://flyovergold.comOr Call 720-605-3900 ► Receive your FREE 52 Date Night Ideas Playbook to make date night more exciting, go to www.prosperousmarriage.comDr. Troy Spurrill is the founder and CEO of Synapse Center for Health and Healing.  He started Synapse over 26 years ago with a vision to bring an integrative approach to healthcare through functional medicine, making Synapse an internationally known center for true health.He received a Bachelor's of Science in Molecular Biology from the University of Manitoba, and a Doctorate of Chiropractic from Northwestern Health Sciences University.  He has extensive training in Functional Neurology, Nutrition, and Applied Kinesiology. Dr. Troy is an author and international lecturer on wellness and brain based healing.  Dr. Troy SpurrillWEBSITE: www.officialsynapse.com -------------------------------------------

https://www.patreon.com/highyieldfamilymedicineIntro (0:35),Screening Guidelines (1:46),Syphilis (2:25),Herpes (4:41),Chancroid (6:52),Gonorrhea (7:47),Chlamydia (9:11),Mycoplasma genitalium (11:00),Lymphogranuloma venereum (12:00),Pelvic Inflammatory Disease (13:16),Disseminated Gonococcal Infection (15:23),Trichomoniasis (16:37),Bacterial Vaginosis (18:03),Vulvovaginal Candidiasis (19:43),Human Papillomavirus (21:01),HIV (22:32),PrEP (24:06),Hepatitis B (25:29),Practice Questions (27:18)

In this episode, we examine the recent retraction of a 2010 study that suggested a link between neonatal hepatitis B vaccination and autism in boys. We break down the methodological flaws that led to its withdrawal, explore related research from the same authors and others, and dive into why establishing causal links between vaccines and autism remains extraordinarily complex. Autism is multifactorial—shaped by genetics, environment, and timing—and we discuss the broader scientific consensus while highlighting the importance of rigorous evidence in public health debates.

Viral hepatitis is an ongoing public health threat, despite the long-standing availability of effective vaccines for hepatitis A and B. Here, experts Paul Kwo, MD, Jewel Mullen, MD, MPH, MPA, FACP, and Su Wang, MD, MPH, FACP, discuss how to incorporate knowledge of hepatitis A and B risk factors and disease burden into patient counseling to enhance uptake of hepatitis A and B vaccines. Topics covered include: The burden of hepatitis A and B in the United States Risk factors for infection Current evidence-based recommendations for hepatitis A and B vaccination.  Follow along with the slides here, and get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Presenters: Paul Y. Kwo, MD Professor of Medicine Director of Hepatology Stanford University School of Medicine Stanford, California Jewel Mullen, MD, MPH, MPA, FACP Associate Professor of Population Health and Internal Medicine University of Texas at Austin Dell Medical School Austin, Texas Su Wang, MD, MPH, FACP Medical Director, Center for Asian Health & Viral Hepatitis Programs Cooperman Barnabas Medical Center/RWJBarnabas-Rutgers Medical Group Assistant Clinical Professor, Rutgers New Jersey Medical Group Florham Park, New Jersey Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Gleich zwei neue Studien zeigen: wer an einer chronischen Hepatitis B erkrankt ist, kann funktionell geheilt werden. Hepatitis B ist eine Lebererkrankung. Autorin: Nele Posthausen Von Daily Good News.

The Nurses Report with Ashley, Nicole, & David – Ashley and Nurse Nicole speak with Ken McCarthy about The Hep B Chronicles, vaccine marketing, serum hepatitis, iatrogenic harm, package inserts, and informed decision-making. The conversation challenges blind trust, explores public health narratives, and urges listeners to read, question, verify, and think before accepting newborn Hepatitis B vaccination claims today...

The Nurses Report with Ashley, Nicole, & David – Ashley and Nurse Nicole speak with Ken McCarthy about The Hep B Chronicles, vaccine marketing, serum hepatitis, iatrogenic harm, package inserts, and informed decision-making. The conversation challenges blind trust, explores public health narratives, and urges listeners to read, question, verify, and think before accepting newborn Hepatitis B vaccination claims today...

The U.S. and Iran reportedly reach a tentative deal to extend their ceasefire by 60 days, a judge declines to block Trump's order restricting mail-in voting, Mexico's congress backs a constitutional amendment adding foreign interference as grounds to annul elections, a deadly school fire kills 16 in Kenya, the U.N. projects a 75% chance that Earth will surpass the 1.5°C threshold by 2030, the DOJ launches a criminal investigation into E. Jean Carroll related to her Trump testimony, a review warns that the U.K.'s youth unemployment crisis could hit 1.25 million by 2031, the EU fines Temu $232 million for failing to stop the sale of illegal and unsafe products, the OpenAI Foundation commits $250 million to help workers and economies adapt to AI disruption, and a new drug shows promise as a functional cure for Hepatitis B infections. Sources: Verity.News

This episode covers hepatitis B.Notes: https://zerotofinals.com/paediatrics/infectiousdisease/hepb/Questions: https://members.zerotofinals.com/Books: https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

In episode 77 of Going anti-Viral, Dr Debika Bhattacharya joins host Dr Michael Saag to discuss the management of hepatitis B virus (HBV) infection and vaccination. Dr Bhattacharya is a Clinical Professor at the University of California Los Angeles (UCLA) David Geffen School of Medicine and specializes in the management of HIV and HIV/viral hepatitis coinfection and sees patients with viral hepatitis and HIV/viral hepatitis coinfection at UCLA and its affiliated clinics. Her research involves viral hepatitis clinical therapeutics and long-term clinical outcomes in persons with HIV/viral hepatitis or viral hepatitis alone. Dr Saag and Dr Bhattacharya discuss HBV infection and vaccination, especially among people with HIV addressing prevalence, serology interpretation, vaccination strategies, and management of hepatitis B in the context of HIV treatment. They also reinforce the need for more research into therapies that will lead to a cure for hepatitis B. 0:00 – Introduction 1:16 – Understanding hepatitis B and its impact on people with HIV  2:56 – Vaccination strategies for hepatitis B 4:53 – Interpreting hepatitis B serology results 8:38 – Vaccination protocols and recommendations 13:19 – Managing patients with hepatitis B 14:29 – Long-acting therapies and hepatitis B risks 17:29 – Screening and monitoring for hepatitis B 19:01 – Navigating core antibody positivity 23:36 – The importance of antibody titers 28:23 – Final thoughts on hepatitis B management Resources: Going-anti-Viral: Episode 31 - Will we ever have a cure for hepatitis B? - Dr Kenneth ShermanYouTube:  https://youtu.be/yh48RFOrISk Apple Podcasts:  https://podcasts.apple.com/us/podcast/episode-31-will-we-ever-have-a-cure-for-hepatitis-b/id1713226144?i=1000677466892 __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

According to Hepatitis Australia, around 220,000 people in Australia are living with chronic Hepatitis B, with 4–5% of cases linked to people born in the Philippines. - Ayon sa Hepatitis Australia, tinatayang nasa 220,000 ang may chronic Hepatitis B sa bansa, 4 hanggang 5 porsyento sa kabuuang bilang ay mula sa Pilipinas.

You can connect with Marilyn Bulloch on LinkedIn here.Read more insights about hepatitis B throughout Hepatitis Awareness Month at Pharmacy Times' Hepatitis Resource Center.Episode Timestamps:1:05: Introduction2:08: Current Disease Burden of Hepatitis B3:55: Risk Landscape for Adults7:20: Link Between Chronic Hepatitis B and Liver Cancer10:25: Expanded Vaccine Recommendations13:25: The Role of Pharmacists in Vaccine Counseling16:40: Why Shorter Conversations Are Better17:55: Advantages of 2-Dose Schedule20:40: Closing the Adult Hepatitis B Immunization Gap23:50: A Patient Counseling Scenario25:25: Closing Thoughts

Episode 223: Oncogenic Viruses Introduction Mehr: Hi everyone, welcome back to the Rio Bravo qweek podcast. Back by popular demand is Me, Mehr Boparai a third-year medical student at COMP-NW. Here with me is Jeremy Pan from COMP who is also a third-year medical student. How are you doing Jeremy? Jeremy: I'm doing great Mehr.Thanks for the kind intro; we had a fun time this morning doing street medicine and had some practice giving Toradol injections and wound dressings. So excited to be back for another podcast episode this afternoon! Mehr: This week, we are moving away from bacteria and antibiotics and diving deeper into cancer-causing viruses. Jeremy: Yes, and if you are interested at all in public health, this is one of those areas where medicine overlaps with public health in a really tangible way. I think one of the most underappreciated aspects of this topic is that we have vaccines that can prevent many of these cancers. If you told someone 50 years ago we'd be vaccinating against cancer, they probably wouldn't believe you! It's amazing to see how far medicine has come. How viruses cause cancer: Jeremy: Before jumping into specific viruses, I always think having a mechanism-based framework makes everything stick better. Mehr: Right, because they don't all cause cancer the same way. Medicine can never be easy huh? Jeremy: Yea…this career really is just a lifetime of discovery. So just to start, in broad terms, we can think of three main buckets of how viruses can cause cancer: Direct oncogenesis where viral proteins interfere with tumor suppressors like P53 and Rb. We will go over their specific mechanisms a little later in the discussion. Mehr:  Chronic inflammation where viruses cause repeated injury through production of reactive oxygen species. They also increase the chance of mutation through repeated DNA replication, leading to cancer.  Jeremy: Immune evasion or suppression leads to decreased tumor surveillance. What this means essentially is that our immune system is constantly removing abnormal cells before they become cancerous. This is completed by CD8 T cells and natural killer, or NK, cells. CD8 T cells recognize abnormal peptides presented on Major Histocompatibility Complex, or MHC, class I molecules and induce apoptosis in those cells. Mehr: And NK cells step in when cells decide to stop expressing MHC I, which abnormal cells like to hide to avoid being caught. So just to reiterate, there are two layers to dissect here: if a cell looks suspicious with an abnormal MHC, CD8 T-cells kill them. If the abnormal cell decides to hide its MHC, then the NK cell will kill it instead. Jeremy: So, for the final big picture, we can think of oncogenic viruses as either disabling tumor suppression, causing chronic damage over time through inflammation, and weakening the immune system's ability to catch cancer in time before it develops. HPV Mehr: Let's start with one of the most common viruses afflicting our population – Human Papilloma Virus otherwise known as HPV.  Jeremy: Right, this notorious virus is probably the most clinically impactful oncogenic virus. The key players HPV utilizes are proteins E6 and E7. Mehr: Right! E6 binds to and inhibits p53, which normally acts to induce cell cycle arrest, and E7 inhibits Rb, which normally acts as a tumor suppressor gene that inhibits the G1 to S phase transition in a normal cell cycle. Jeremy: So essentially, we are losing both apoptosis and losing cell cycle control at the same time. What is interesting about HPV is that persistent infection, not just exposure to the virus, is what drives cancer risk.  Mehr: Exactly, most HPV infections clear on their own, but the ones that persist are the problem. Clinically, many end up being asymptomatic. However, for high-risk infections, we can see genital warts that can itch, feel tender, or cause abnormal vaginal bleeding and discharge. Patients are sometimes not able to have a vaginal delivery because of the warts that are present along their genital tract. We can also see warts on the hands and fingers or plantar surface of our feet. Jeremy: Another interesting point is that we are also seeing a shift where there are more cases of oropharyngeal cancers in younger, non-smoking patients. This is why if we see an abnormal neck lymph node or persistent sore throat after swallowing in a young patient, HPV should definitely be on the differential.  Mehr: Screening is very important as well! We typically discover high-risk HPV infections through routine Pap smears and other HPV specific tests through DNA PCR and RNA tests. We also encourage vaccination for effective prevention of both genital warts and high-risk HPV-related cancers. There was also a study in Scotland where there were zero cases of HPV in adults who received the vaccine between 12-13 years of age! Which is crazy!  EBV HBV & HCV Mehr: Now let's shift to viruses that affect the liver, Hepatitis B virus and Hepatitis C virus. Jeremy: Both are strongly associated with hepatocellular carcinoma, but they actually get there in slightlydifferent ways. Mehr: Right. Hepatitis B is a DNA virus that can integrate directly into the host genome, which can disrupttumor suppressor genes and promote oncogenesis. Jeremy: Whereas Hepatitis C is an RNA virus, so it doesn't integrate into the host genome. Instead, it causes chronic inflammation Over time, that leads to repeated cycles of hepatocyte injury and regeneration, along withoxidative stress from reactive oxygen species, which increases the risk of DNA mutations. Mehr: One really important clinical pearl is that Hep B can actually cause hepatocellular carcinoma evenwithout cirrhosis. Whereas with Hep C, the pathway is usually chronic inflammation → fibrosis → cirrhosis → dysplasia→ cancer.  Jeremy: So, screening becomes really important for both of these viruses. For high-risk patients—like those with chronic hepatitis or cirrhosis—we typically dosurveillance with liver ultrasound every 6 months, sometimes with alpha-fetoprotein levels to see if it is elevated. Mehr: From a prevention standpoint, the Hep B vaccine is a huge win. It significantly reduces the risk ofhepatocellular carcinoma. For Hep C, we don't have a vaccine, but direct-acting antivirals can actually cure the infection andreduce long-term cancer risk, which is why we screen between ages 18-79  nowadays. Global Hep B and C account for 65% of all HCC cases! So, it makes sense that primary care itself is increasing the treatment of Hep C cases as well since it is easier to prescribe and that you want to be treated ASAP.  Jeremy: Yea, the ability to treat Hep C is so beneficial to population health. Now let's say you have a patient who develops hepatocellular carcinoma, options can include surgicalresection, liver transplantation, local therapies, or systemic treatments depending on stage.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  __________________________________ References: Barry H. C. (2024). Scottish Screening: No Cases of Invasive Cervical Cancer in Women Who Received at Least One Dose of Bivalent HPV Vaccine at 12 or 13 Years of Age. American family physician, 110(2), 201–202. https://pubmed.ncbi.nlm.nih.gov/39172683/ Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!

Listen as Bright Ansah, patient advocate, describes his experience with being diagnosed with chronic hepatitis B as a recent immigrant to the United States and the unique barriers to treatment faced by the African immigrant community. Through his story, learn how healthcare professionals can reduce these barriers for this key population. Topics covered include: Key barriers to care for African immigrant patients Myths and misconceptions about HBV in the African immigrant community Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Link to program page: https://bit.ly/4uz25Vc Presenter: Bright Ansah  HBV Patient Advocate Frederick, Maryland Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Hepatitis B virus (HBV) infection affects around 254 million people worldwide and causes more than 1 million deaths annually. Author Anna Lok, MD, from the University of Michigan discusses HBV transmission, screening, and treatment with JAMA Associate Editor Beverly Forsyth, MD. Related Content: Hepatitis B Hepatitis B Virus Treatment Gaps in the US Tenofovir and Hepatitis B Virus Transmission During Pregnancy US Newborn Hepatitis B Virus Vaccination Rates

Welcome to Pulse: Amplify, where we sit down with the leaders and changemakers shaping the future of health. In this episode Louise and George sit down with Dr Mehmood Khan, CEO of Hevolution Foundation, and Her Royal Highness Princess Dr Haya Bint Khaled Bin Bandar Al Saud, Senior Vice President of Research at Hevolution. Based in Riyadh and backed by Saudi Arabia's Vision 2030, Hevolution is the world's largest philanthropic funder of healthspan science, with over USD $400 million allocated in just three years.Timed with the release of the second edition of Hevolution's Global Healthspan Report - the most comprehensive look at the field across 23 countries - this conversation moves beyond the longevity hype to explore what it takes to extend healthy human life for the benefit of all.In this episode:Healthspan, not longevity - Why Hevolution is focused on keeping people physically, mentally, and financially independent, and why a global non-profit is the right vehicle for a challenge governments and private enterprise can't tackle alone.Why Saudi Arabia, why now - Princess Dr Haya on the demographic shift driving the kingdom's leadership, and why a young population on the brink of ageing is uniquely placed to redesign systems before they break.The science that has scientists excited - GLP-1 agonists, senotherapeutics, CRISPR, and cellular reprogramming, and why the real breakthrough is the convergence of these fields, not any one of them in isolation.A jaw-dropping case study - Dr Khan walks through how rejuvenating aged liver cells eliminated chronic Hepatitis B in animal models, with first-in-human trials now underway. A profound example of aging biology rewriting the rules for treating incurable diseases.What clinicians need to know - Two-thirds of healthcare professionals are now getting monthly healthspan questions from patients. Princess Dr Haya on the shift from reactive to proactive care, and the urgent need for evidence-based healthspan protocols.A message for policymakers - Why the Minister of Finance, not just the Minister of Health, needs to be at the table, and why retirement, education, and workforce policies built for a 1%-over-65 world are catastrophically out of date.Where digital health innovators should be looking - The five years that could be cut from drug development with better data tools, the four proven interventions that lend themselves to digital monitoring, and why we already have the technology - just not the policy frameworks to deploy it.Connect with Hevolution on LinkedInVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+IT

For US veterans, support for continued engagement in hepatitis B (HBV) care has been lacking. Listen in as Richelle M. Gaiter, DMSc, MPAS, Med, shares her experiences with HBV care as an Air Force veteran and what can be done to improve HBV care for veterans and civilians alike. Topics include:  Key barriers to HBV care for US veterans What has improved in the last decade Strategies for improved engagement in care Get access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Diseases Podcast on Apple Podcasts, YouTube Music, or Spotify. Link to program page:https://bit.ly/4vAqSJT Presenter: Richelle M. Gaiter, CMSGT Retired USAFR, DMSc, MPAS, Med Family Medicine, Prevention, Patient Education Crescent City, California Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Anousha and Bright speak with Dr. Chloe Thio and Dr. David Thomas, academic medical researchers at the Johns Hopkins School of Medicine, about a new NIH grant supporting a Johns Hopkins–led consortium focused on finding a cure for hepatitis B. They discuss the goals of the $24 million award, the importance of collaborative science, and what this investment could mean for the future of hepatitis B research and for people living with the disease.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Dr. David Hilmers is one of my heroes. We respect, honor, and love Dr. Hilmers. Some lives do not move in a straight line. They arc. They climb, break, turn, and then rise again in a direction no résumé can fully explain. Dr. David Hilmers has lived that kind of life. He was a Marine aviator. A NASA astronaut on four Space Shuttle missions. An engineer. A man who saw the Earth from the cold black silence of space and logged more than twenty days above it. By any ordinary telling, that would have been enough. More than enough. The kind of life that earns applause, headlines, and a comfortable place in memory. But there is another kind of greatness. Quieter. Harder. Less decorated. It doesn't ask, “How far did you go?” It asks, “Whom did you serve once you got there?”That is where the story of David Hilmers becomes truly significant. Many define true significance as using your gifts to meaningfully improve the lives of others at scale. In Hilmers' case, those are not just handsome words. They are the contour lines of a real life. He saw the whole Earth, and instead of marveling only at its beauty, he felt its pain. He looked down from orbit and began looking inward. And what he found there was not self-congratulation. It was a calling.Become a supporter of this podcast: https://www.spreaker.com/podcast/success-made-to-last-legends--4302039/support.

On this week's Tech Nation, you are smarter than you know - Dr. Angus Fletcher talks about “Primal Intelligence”... then Dr. Derek Jantz from Tune Therapeutics explains how they aim to "tune" DNA - not just with human DNA, but stopping the Hepatitis B virus in its tracks.

The vaccination schedule for your baby can feel daunting. It also may seem a little strange,  you might wonder why a newborn needs to be protected against Hepatitis B? Between frequent visits to the pediatrician and fears you might have over adverse reactions to the vaccines, many parents wonder how they can best support their child.  In this episode of Yoga|Birth|Babies I speak with holistic pediatrician Dr. Ana-Maria Temple about newborn and childhood vaccinations. In an easily digestible manner, she explains the vaccines babies are given and why they are given at such a young age. We discuss the possibility to delay certain vaccines and why a parent might consider doing that. Dr. Temple also offers resources and questions you might ask your pediatrician to get everyone working together and ensure care is aligned with your family's goals. As Dr. Temple says “If you understand the why, you can then make decisions and choices.”  Get the most out of each episode by checking out the show notes with links, resources and other related podcasts at: prenatalyogacenter.com Don't forget to grab your FREE guide, 5 Simple Solutions to the Most Common Pregnancy Pains HERE  If you love what you've been listening to, please leave a rating and review! Yoga| Birth|Babies (Apple) or on Spotify! To connect with Deb and the PYC Community:  Instagram & Facebook: @prenatalyogacenter Youtube: Prenatal Yoga Center Learn more about your ad choices. Visit megaphone.fm/adchoices

What actually happens to your baby in the first 24–48 hours after birth, and which newborn interventions should you say yes or no to?In this episode, we break down 14 common newborn interventions and procedures parents may be offered right after delivery. From delayed cord clamping and suctioning to vitamin K, hepatitis B, erythromycin eye ointment, newborn metabolic screening, hearing and heart tests, circumcision, jaundice, early bathing, and pediatric follow-up, we explain what these interventions are, why they're offered, and what parents should understand before birth.Whether you're planning a hospital birth, home birth, or birth center delivery, this conversation will help you make informed decisions about newborn care and know what questions to ask when creating your birth plan.00:00 Trailer + intro01:13 Why newborn interventions matter03:44 Delayed cord clamping09:23 Rubbing and suctioning after birth14:26 Swaddling, hats, and skin-to-skin18:37 The golden hour and delaying newborn exams21:10 Vitamin K shot vs oral vitamin K29:44 Hepatitis B vaccine at birth34:07 Erythromycin eye ointment36:57 Newborn metabolic screening / heel prick / PKU test39:19 Newborn blood sugar testing41:42 Hearing test and congenital heart disease screening46:36 Circumcision considerations47:32 Early bath and newborn microbiome52:31 Newborn jaundice explained56:39 Breastfeeding jaundice vs breast milk jaundice59:04 Pediatrician visits and delayed vaccine schedules01:05:39 Closing thoughtsResources From This Episode:Vax Dilemmas: Hesitancy, Studies, and Alternate Schedules with Dr. Joel Gator Warsh | Ep. 109 - https://youtu.be/d72t0Dv18Ok?si=OawY6xJOcWhy0w44Vaccines From A Neurodevelopmental Perspective with Dr. Ari Calhoun | Ep. 52 - https://podcasts.apple.com/us/podcast/healthy-as-a-mother/id1663942916?i=10006483825895 Things That Ruin Breastfeeding | Ep 146 - https://youtu.be/BQgB9rQ_Msk?si=fwrB0QJ1DvfzrrUmBreastfeeding and Trying To Conceive | Ep 113 - https://youtu.be/vRXXioExVh8?si=epAYIrJeqe197ftJBreastfeeding: What to KNOW before your baby is born | Ep 10 - https://podcasts.apple.com/us/podcast/healthy-as-a-mother/id1663942916?i=1000601146225Find more from Dr. Leah:Dr. Leah Gordon | InstagramDr. Leah Gordon | WebsiteWomanhood Wellness | WebsiteFind more from Dr. Morgan:Dr. Morgan MacDermott | InstagramDr. Morgan MacDermott | WebsiteUse code HAAM and save 10% at FondUse code HEALTHYMOTHER and save 15% at RedmondFor 20% off your first order at Needed, use code HEALTHYMOTHERSave $260 at Lumebox, use code HEALTHYASAMOTHER

Send Zorba a message!Zorba lays out a plan for taking action regarding the CDC rolling back universal Hepatitis B vaccination recommendations for newborns, which goes against widespread public health consensus.(Recorded December 5, 2025)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

Send Zorba a message!Zorba lays out a plan for taking action regarding the CDC rolling back universal Hepatitis B vaccination recommendations for newborns, which goes against widespread public health consensus.(Recorded December 5, 2025)Support the showProduction, edit, and music by Karl Christenson Send your question to Dr. Zorba (he loves to help!): Phone: 608-492-9292 (call anytime) Email: askdoctorzorba@gmail.com Web: www.doctorzorba.org Stay well!

In this episode, Michelle Liu, Advocacy and Engagement Program Manager at the Hepatitis B Foundation, joins us to discuss the Foundation's storytelling programs and their impact. She shares how uplifting the voices of people with lived experience helps reduce stigma, build community, and empower individuals affected by hepatitis B and liver cancer.Support the showOur website: www.hepb.orgSupport B Heppy!Social Media: Instagram - Twitter - Facebook

Wie geht man als mündiger, lebenslustiger Mensch mit Geschlechtskrankheiten um? Wie sollte man sich verhalten, was sollte man wissen, wie oft sich testen lassen? Das habe ich Mirjiam Hall gefragt. Sie ist Gynäkologin und Vorsitzende der Aids Hilfe Wien. Wie man Risiken reduziert, ohne sich verrückt zu machen.

In the second part of this 20-Minute Health Talk podcast with Peter Hotez, MD, pediatrician, scientist and global health advocate, the conversation with host Chethan Sathya, MD, shifts to the front lines of health care. Dr. Hotez offers practical advice for clinicians and the public on navigating medical misinformation and myths, such as "turbo cancers.” He also reveals yet another good reason to get your Covid and flu shots — to protect your heart. As he explores the critical public health importance of childhood vaccines like the MMR and Hepatitis B, Dr. Hotez explains the real-world consequences of declining vaccination rates. Finally, he offers his frank assessment of the political and financial forces driving the anti-science movement and how to rebuild public trust. This is Part 2 of this series. Listen to Part 1 About Northwell Health Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch more episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. 

Episode 213: HIV PrEP Review H. Nicole Magaña, medical student, reviews the history of PrEP and outlines the currently FDA-approved medications used for HIV prevention. Dr. Arreaza provides additional perspective on long-acting injectable options, including how quickly they begin to protect patients after initiation.   Written by Nicole Magana, MSIV, American University of the Caribbean. Comments and edits by Hector Arreaza, MD. You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice. Pre-exposure prophylaxis for HIV. Previous episodes related to HIV:  -Episode 67, HIV history (September 2021) -Episode 68, HIV transmissibility (October 2021) -Episode 70 (October 2021), HIV prevention (including HIV Prep with oral medications) -Episode 98 (June 2022), we introduced Apretude, the first injectable for HIV PrEP. Apretude was approved in December 2021.  What is Pre-Exposure prophylaxis (PrEP)? Pre-exposure prophylaxis, or PrEP, is the use of antiretroviral medications taken by individuals who are HIV-negative to prevent HIV acquisition. There are 30,000 new HIV infections annually in the US.  How effective is it? When taken as prescribed, PrEP is highly effective at reducing the risk of HIV transmission through sexual exposure and injection drug use. Patients who are adherent to PrEP can lower their risk of contracting HIV by 99%. The effectiveness of oral PrEP is highly adherence dependent. In trials with 70% adherence, the relative risk of HIV acquisition was 0.27, compared to 0.51 with 40-70% adherence and no significant benefit with adherence ≤40%. How does PrEP work? PrEP works by maintaining therapeutic drug levels in the bloodstream and in target tissues. If HIV exposure occurs, viral replication is inhibited, preventing the establishment of infection. Brief History of PrEP. The concept of PrEP originated from early animal studies demonstrating that antiretroviral medications could prevent retroviral transmission when administered before exposure. In 2010, the iPrEx trial showed that daily oral tenofovir disoproxil fumarate (known as Truvada) with emtricitabine significantly reduced HIV acquisition among men who have sex with men and transgender women. This was the first large clinical trial to demonstrate the effectiveness of PrEP. In 2012, the FDA approved oral Truvada, which is TDF/FTC (tenofovir disoproxil and emtricitabine) for HIV prevention. Since then, additional studies have expanded indications and introduced new formulations, including long-acting injectable options. Who Should Be Offered PrEP? PrEP should be considered for any HIV-negative individual at increased risk of HIV acquisition, including Men who have sex with men, transgender individuals, heterosexual men and women with an HIV-positive partner, individuals with recent bacterial sexually transmitted infections, people who inject drugs, individuals engaging in condomless sex with partners of unknown HIV status. Remember that PrEP should be offered in a nonjudgmental, patient-centered manner, make it a safe space to talk openly about prevention of HIV.  Available HIV PrEP Options. Daily Oral PrEP: There are 2 formulations of Tenofovir. There is Tenofovir disoproxil fumarate (TDF)/ Truvada and Tenofovir alafenamide (TAF)/ Descovy. Each is available in a tablet combined with Emtricitabine a nucleoside reverse transcriptase inhibitor. Truvada: It is approved for all populations at risk through sexual exposure or injection drug use. Something to look out for before starting this medication is for pre-existing CKD. Do not give to patients who have an estimated glomerular filtration rate of less than 60 mL/min. (6) Descovy: This option is approved for men who have sex with men and transgender women but is not approved for individuals at risk through receptive vaginal sex. It has less impact on renal function and bone mineral density compared to Truvada. It can be used in moderately reduced kidney function (GFR between 30-60 mL/min). Truvada and Descovy are taken orally once a day.  After patients start taking these medications, when are they considered to be protected?  Nicole: With daily oral PrEP, guidelines differ with WHO and International Aids Society-USA stating it takes about 7 days, while CDC states 21 days to allow for adequate concentration in tissues (1). Adherence is critical for efficacy. Injectable HIV PrEP. In 2021, the FDA approved the first Injectable PrEP option Long-acting cabotegravir (CAB-LA)- known on the market as Apretude. Cabotegravir is an integrase strand transfer inhibitor administered as an intramuscular injection.Dosing consists of an initial injection, a second injection one month later, and then maintenance injections every two months (1). Another option is Lenacapavir (Yeztugo). The Yeztugo as a pre-exposure prophylaxis (PrEP) for HIV in Oct 2024. Yeztugo is the first and only FDA-approved HIV prevention treatment that requires just two injections per year, offering a long-acting option for people who weigh at least 35kg. It is given as 2 injections every 6 months. First dose is given with 2 tablets on Day 1 and Day 2, then every 6 months 2 injections on the same day. Clinical trials, including HPTN 083 and HPTN 084, demonstrated that injectable cabotegravir is superior to daily oral PrEP in preventing HIV infection. This advantage is largely due to improved adherence rather than differences in intrinsic drug potency. There have been no head-to-head comparisons between Yeztugo and Apretude, but they are both very effective. Apretude starts protecting 7 days after the first dose, and Yeztugo starts protecting 2 hours after Day 2 (if patient takes the oral loading dose) or 3-4 weeks if no oral load is taken. Injectable PrEP is particularly beneficial for patients who struggle with daily pill adherence, have trouble swallowing pills, prefer a discreet option, have difficulty storing their medication or have renal or bone disease that limits the use of tenofovir-based regimens like Truvada and Descovy (6). In one unpublished report by Medline, patients who received Apretude had an increase in bone mineral density compared to those who received Truvada (1). Tests prior to starting PrEP. Before initiating PrEP, patients must be confirmed to be HIV-negative. Baseline evaluation includes HIV testing with a fourth-generation antigen/antibody assay, HIV RNA testing if acute infection is suspected, renal function testing for oral PrEP, Hepatitis B screening, sexually transmitted infection screening, and pregnancy testing when appropriate. PrEP should not be started in individuals with known or suspected acute HIV infection. Monitoring for patients on HIV PrEP. Monitoring typically includes HIV testing every 2 to 3 months, STI screening every 3 to 6 months, renal function monitoring for those on oral PrEP (tenofovir- based), ongoing adherence and risk-reduction counseling. And for injectable PrEP, adherence to the injection schedule is essential, as delayed dosing may increase the risk of resistance if HIV infection occurs. HIV PrEP is not a prevention for other STIs. Screening for STIs and counseling about prevention is essential. Breakthrough HIV infections on PrEP are rare and most often associated with poor adherence or delayed diagnosis. Truvada is more studied in all populations and is considered safe during pregnancy and breastfeeding. There is less data regarding the injectable option in patients who are pregnant, may become pregnant, or whose primary risk factor is injection drug use (1). Injectable PrEP provides an important alternative for patients with chronic kidney disease and bone disease (1). Key Takeaway Pre-exposure prophylaxis is a safe, effective, and evidence-based strategy for HIV prevention. With both daily oral and long-acting injectable options available, PrEP can be individualized to meet patient needs. Normalizing PrEP discussions in clinical practice is essential to reducing new HIV infections and advancing public health goals.  Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week!  References: Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society–USA Panel. The Journal of the American Medical Association. 2025. Gandhi RT, Landovitz RJ, Sax PE, et al. Long-Acting Lenacapavir Acts as an Effective Preexposure Prophylaxis in a Rectal SHIV Challenge Macaque Model. The Journal of Clinical Investigation. 2023. Bekerman E, Yant SR, VanderVeen L, et al. Pharmacokinetics and Safety of Once-Yearly Lenacapavir: A Phase 1, Open-Label Study. Lancet. 2025. Jogiraju V, Pawar P, Yager J, et al.

In this podcast, Kyle welcomes Aaron Siri, a prominent legal advocate known for his work with the Informed Consent Action Network (ICAN) and Del Bigtree's Highwire, who has been influential in uncovering pharmaceutical industry practices. The conversation revolves around Siri's new book, 'Vaccines. Amen,' which critiques the almost religious zeal with which vaccines are regarded and delves into various controversial aspects of vaccine safety and policy. Siri discusses the deficiencies in safety testing of vaccines, such as the Hepatitis B vaccine trials involving infants, and highlights how the 1986 National Childhood Vaccine Injury Act shifted the responsibility of vaccine safety from manufacturers to the federal government, resulting in a lack of accountability. The conversation also explores the history and efficacy of the Measles vaccine, potential long-term health impacts of vaccines, and the broader implications of governmental and pharmaceutical industry practices. Kyle and Siri emphasize the importance of individual choice and informed consent in vaccination decisions, criticizing the lack of transparency and the ethical implications of government-mandated vaccines. The discussion concludes with reflections on the future of vaccine policy and the importance of maintaining personal freedoms and rights. Aaron Siri is the managing partner of Siri and Glimstad, where he focuses on civil rights, informed consent, class actions, and complex civil litigation. His work includes challenging medical mandates, defending parental rights, representing whistleblowers, and forcing government transparency, including litigation that compelled the FDA to release Pfizer COVID 19 records. Aaron previously practiced at Latham and Watkins and clerked for the Chief Justice of the Supreme Court of Israel. He earned his law degree from UC Berkeley School of Law, where he served as Editor in Chief of the Berkeley Business Law Journal.   From Kyle: The Community is coming! Click here to learn more   Connect with Aaron here: Instagram Website Siri & Glimstad LLP   Our Sponsors: Let's level up your nicotine routine with Lucy. Go to Lucy.co/KKP and use promo code (KKP) to get 20% off your first order. Lucy offers FREE SHIPPING and has a 30-day refund policy if you change your mind.   Connect with Kyle: I'm back on Instagram, come say hey @kylekingsbu Twitter: @kingsbu Our Farm Initiative: @gardenersofeden.earth Odysee: odysee.com/@KyleKingsburypod Youtube: https://www.youtube.com/@Kyle-Kingsbury Kyle's Website: www.kingsbu.com - Gardeners of Eden site If you enjoyed this podcast, please subscribe & leave a 5-star review with your thoughts!

In this episode, Lindsey sits down with pediatrician Dr. Joel Warsh a.k.a. Dr. Gator, author of Between a Shot and a Hard Place, for the conversation every mom needs to hear. Get an honest look at vaccine safety, parental autonomy, and trusting your intuition in a world of conflicting advice. Ahead, Lindsey + Dr. Gator dive into the chronic illness epidemic—exploring everything from the long-term effects of vaccines to the rise in allergies, autism, and autoimmune conditions in kids today. You'll learn why asking questions isn't “woo-woo”—it's essential to make informed choices.  If you've ever felt judged for going “off schedule” or considered an alternative vaccine approach, this episode brings nuance, compassion, and real data. From toxic ingredients to finding the right doctor, don't miss this must-listen for parents who care about wellness, safety, and sovereignty. We also talk about: The real reasons vaccine schedules have skyrocketed in recent decades What ingredients in vaccines could mean for your child's health Why most doctors won't see families who want alternative vaccine schedules—and what to do about it Debunking the “safe and effective” narrative + what parents actually want to know The myth vs. reality of vaccine injury reporting (VAERS) + what gets missed Pros + cons of delaying or spacing out vaccines—and how to weigh the risks The truth about Hepatitis B at birth, polio, and why some shots might be less urgent than you think Autism, MMR, and the data gaps that you need to hear about Finding “your people” as a parent when conversations around vaccines feel taboo Empowerment tips on trusting your gut, advocating for your child, and demanding better research Resources: Instagram: @drjoelgator X: @drjoelgator Book: www.theshotbook.com Order our book, Almost 30: A Definitive Guide To A Life You Love For The Next Decade and Beyond, here: https://bit.ly/Almost30Book.  Sponsors: Fatty15 | Get an additional 15% off their 90-day subscription Starter Kit by going to fatty15.com/ALMOST30 and use code ALMOST30 at checkout.  Ka'Chava | Go to kachava.com and use code ALMOST30 for 15% off your next order. Hero Bread | Hero Bread is offering 10% off your order. Go to hero.co and use code ALMOST30 at checkout. Revolve | Shop at REVOLVE.com/ALMOST30 and use code ALMOST30 for 15% off your first order. #REVOLVEpartner BetterHelp | This episode is brought to you by BetterHelp. Give online therapy a try at betterhelp.com/almost30 and get on your way to being your best self with 10% off your first month. Chime | It just takes a few minutes to sign up. Head to Chime.com/ALMOST30. Paleovalley | Head to paleovalley.com/almost30 for 15% off your order! Our Place | Visit fromourplace.com/ALMOST30 and use code ALMOST30 for 10% off sitewide.  To advertise on this podcast please email: partnerships@almost30.com. Learn More: https://almost30.com/about https://almost30.com/morningmicrodose https://almost30.com/book Join our community: https://facebook.com/Almost30podcast/groups https://instagram.com/almost30podcast https://tiktok.com/@almost30podcast https://youtube.com/Almost30Podcast Podcast disclaimer can be found by visiting: almost30.com/disclaimer.  Almost 30 is edited by Garett Symes and Isabella Vaccaro. Learn more about your ad choices. Visit megaphone.fm/adchoices

It's time to build your family's future on a foundation of true health and freedom. Join us at Future Foundations—because your future generations deserve the best start to the mission that will outlive us… Check it out here. Use code FREEDOM25 for 25% off!    Whether you're looking for tinctures, topicals or teas or a deeper connection to your INNATE healing capacity, Noble Task Homestead is here to serve you. Join the movement. Visit NobleTaskHomestead.com/noblestan today and enjoy a 10% discount on your order.   San Diego area residents, take advantage of our special New Patient offer exclusively for podcast listeners here. We can't wait to experience miracles with you!   Welcome to another episode of the Future Generations Podcast! In this conversation, Dr. Stanton Hom welcomes back Dr. Andrew Kaufman, a "recovering physician" known for challenging mainstream narratives on viruses, vaccines, and chronic illness. Together they unpack vaccine mandates, the 1986 liability shield, and how government intervention reshaped the market for vaccines. They then dive into turpentine as a traditional, evidence-backed remedy, how it works as a lipophilic detox tool, and practical ways families can safely apply it. Dr. Kaufman also outlines his natural-healing workshops and a vision of healthcare where families rely less on institutions and more on their own wisdom, community, and responsibility.   Highlights: "The only way we can change these harmful societal forces is by making decisions and taking action for ourselves."   "It wasn't the diagnoses that came first. It was the drugs, and then they built a system to convince everyone they're mentally ill."    "It's not the substance that does the curing. It's your body that does the cure."    "The only sustainable model is when we get people so well that they never need us and they never need the system."    Timestamps: 00:01 – Introduction 00:56 – Dr. Andrew Kaufman Introduces Himself as a "Recovering Physician" 02:18 – Harm Reduction, Hepatitis B at Birth, and Questioning Immunity 06:57 – Vaccine Liability, the 1986 Act, and the Vaccine Court 11:24 – Questioning Government Authority and the Illusion of Control 20:52 – From Cancer Medicine and Psychiatry to Natural Healing 25:12 – Turpentine Enters the Conversation: History and Normalizing It 34:40 – Practical Ways to Use Turpentine: Topical and Inhalation 43:23 – Inside the Turpentine Workshop and Fellowship Support 48:32 – How Dr. Kaufman Would Approach Vaccine-Related Injuries   Resources:   Remember to Rate, Review, and Subscribe on iTunes and Follow us on Spotify!   Learn more about Dr. Stanton Hom on:   Instagram: https://www.instagram.com/drstantonhom  Website: https://futuregenerationssd.com/    Podcast Website: https://thefuturegen.com Twitter: https://twitter.com/drstantonhom  LinkedIn: https://www.linkedin.com/in/stanhomdc  Stay Connected with the Future Generations Podcast:   Instagram:  https://www.instagram.com/futuregenpodcast  Facebook: https://www.facebook.com/futuregenpodcast/    Links:    https://www.thehivemethod.co/ https://www.instagram.com/thehivemethod.co   About Dr. Andrew Kaufman, M.D. Dr. Andrew Kaufman is a psychiatrist, forensic expert, and outspoken critic of modern psychiatry. Drawing from decades inside the mental health system, he challenges mainstream narratives around diagnosis, medication, and "mental illness," offering a psycho-spiritual perspective that empowers individuals to reclaim authority over their mental, emotional, and physical health. Social links:  https://www.instagram.com/andrewkaufmanmd?igsh=MWZjamt2OWd5ajNzdQ==  https://www.instagram.com/medauthentica?igsh=MXZwNTRmejQ1NTVrag==  The desire to go off grid and have the ability to grow your own food has never been stronger than before. No matter the size of your property, Food Forest Abundance can help you design a regenerative layout that utilizes your resources in the most synergistic and sustainable manner. If you are interested in breaking free from the system, please visit www.foodforestabundance.com and use code "thefuturegen" to receive a discount on their incredible services.   Show your eyes some love with a pair of daylight or sunset (or both!) blue-light blocking glasses from Ra Optics. They have graciously offered Future Generations podcast listeners 10% off any purchase. Use code FGPOD or click here to access this discount, and let us know how your glasses are treating you!   One of the single best companies whose clean products have supported the optimal wellness of our family is Earthley Wellness. Long before there was a 2020, Kate Tetje and her team have stood for TRUTH, HEALTH and FREEDOM in ways that paved the way for so many of us. In collaboration with this incredible team, we are proud to offer you 10% off of your first purchase by shopping here.   Are you concerned about food supply insecurity? Our family has rigorously sourced our foods for over a decade and one of our favorite sources is Farm Match and specifically for San Diego locals, "Real Food Club PMA". My kids are literally made from their maple breakfast sausage and the amazing carnitas we make from their pasture raised pork. We are thrilled to share 10% off your first order when you shop at this link.   Another important way to bolster food security is by supporting local ranchers. Our favorite local regenerative ranch is Perennial Pastures. They have the best nutrient-dense meats that are 100% grass-fed and pasture-raised. You can get $10 off of your first purchase when you use the code: "FUTUREGENERATIONS" at checkout. Start shopping here.  

In this powerful conversation, Dr. Tony Ebel sits down with Del Bigtree, founder of ICAN (Informed Consent Action Network) and host of The Highwire, to discuss the critical intersection of nervous system health, vaccines, and chronic childhood illness. Del shares groundbreaking insights into vaccine safety research (or lack thereof), while Dr. Tony reveals his clinical discoveries about the "perfect storm" - how birth trauma, nervous system dysregulation, and toxic exposure create the foundation for adverse vaccine reactions in some children but not others. This episode covers the shocking truth about vaccine safety studies, the 80-90% correlation between birth interventions and autism, the connection between colic and autism, and the incredible momentum of the MAHA movement toward medical freedom.-----Del's Social Media and Websites:https://thehighwire.comhttps://icandecide.orghttps://x.com/delbigtree?s=20https://www.instagram.com/delbigtree/https://www.aninconvenientstudy.com-----Key Topics & Timestamps06:00 Why do some kids react to vaccines while others don't?09:00 Autism as a detoxification disorder: Aluminum, methylation, and MTHFR13:00 Autism as brain injury: Understanding the inflammatory connection20:00 The perfect storm: Birth trauma, pregnancy stress, and toxic load23:00 The 80-90% statistic: Birth trauma correlation with chronic illness25:00 Colic to autism: They were never growing out of it29:00 Action step: How to find vaccine package inserts - Section 6.131:00 The Hepatitis B scandal: 147 children, 5 days, no placebo40:00 The pediatrician paradox: Why refuse to care for unvaccinated kids?54:00The presidential suite meeting: Del tells RFK Jr. to run for president58:00 In the Oval Office: Watching RFK Jr. sworn in - beyond our wildest dreams1:04:00 An Inconvenient Study: The pro-vaccine researcher's confession on camera-- Follow us on Socials: Instagram: @pxdocs Facebook: Dr. Tony Ebel & The PX Docs Network Youtube: The PX Docs For more information, visit PXDocs.com to read informative articles about the power of Neurologically-Focused Chiropractic Care. Find a PX Doc Office near me: PX DOCS DirectoryTo watch Dr. Tony's 30 min Perfect Storm Webinar: Click Here

OA1227 - Come play the worst ever round of the Connections game and figure out what on earth Tuskegee Alabama, the CDC, Southern Denmark University, and the West African country of Guinea-Bissau all have in common, as RFK Jr. continues his campaign of “just asking questions” that we already have the answer to. Black men untreated in Tuskegee syphilis study. Heller, J. (July 25, 1972; republished May 10, 2017). Associated Press. The untreated syphilis study at Tuskegee timeline. Centers for Disease Control. (September 4, 2024). 45 CFR 46 Protection of Human Subjects. (Department of Health and Human Services regulations to implement the National Research Act and create Institutional Review Board policies). Hepatitis B. World Health Organization (July 23, 2025). Should the U.S. model its vaccine policy on Denmark's? Experts say we're nothing alike. Godoy, M. (December 26, 2025). NPR. RFK Jr. overhauls childhood vaccine schedule to resemble Denmark's in unprecedented move. Lovelace Jr., B., Edwards, E., Fattah, M., & Bendix, A. (January 5, 2026). NBC News. What is actually the emerging evidence about non-specific vaccine effects in randomized trials from the Bandim Health Project? Støvring, H., Ekstrøm, C.T., Schneider, J.W., & Strøm, C. (2025). Vaccine, 68, 1-4. Notice of award of a single source unsolicited grant to fund University of Southern Denmark (SDU). Department of Health and Human Services. (December 15, 2025). U.S. plan for $1.6m hepatitis B vaccine study in Africa called ‘highly unethical'. Schreiber, M. & Lay, K. (December 19, 2025). The Guardian. CDC awards $1.6 million for hepatitis B vaccine study by controversial Danish researchers. Szabo, L. (December 18, 2025). Center for Infectious Disease Research and Policy. CDC funds controversial hepatitis B vaccine trial in African newborns. Offord, C. (December 18, 2025). Science Insider. Research ethics and compliance support. Southern Denmark University. Further reading: Qiao, H. (2018). A brief introduction to institutional review boards in the United States. Pediatric Investigation, 2, 46-51. U.S. Department of Health and Human Services. International compilation of human research standards. https://www.hhs.gov/ohrp/international/compilation-human-research-standards/index.html University of North Carolina. Nuremberg Code. https://research.unc.edu/human-research-ethics/resources/ccm3_019064/ Torrance, R.J., Mormina, M., Sayeed, S., Kessel, A., Yoon, C.H., & Cislaghi, B. (2024). Is the U.N. receiving ethical approval for its research with human participants? Journal of Medical Ethics, 51, 1-4. Barchi, F. & Little, M.T. (2016). National ethics guidance in Sub-Saharan Africa on the collection and use of human biological specimens: A systematic review. BMC Medical Ethics, 17, 1-25. Salhia, B. & Olaiya, V. (2020). Historical perspectives on ethical and regulatory aspects of human participants research: Implications for oncology clinical trials in Africa. JCO Global Oncology, 6, 959-965. Check out the OA Linktree for all the places to go and things to do!

TWiV explains how the dengue virus protein NS1 alters Aedes aegypti midgut permeability and favors virus dissemination, and achieving a complete hepatitis B virus cure in chronic hepatitis B virus-infected humanized mice by using a capsid assembly modulator. Hosts: Vincent Racaniello, Alan Dove, and Angela Mingarelli Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Support science education at MicrobeTV ASV 2026 Positions in Rosenfeld Lab (email) Dengue virus NS1 alters mosquito midgut permeability (mBio) HBV cure with a capsid assembly modulator (Cell Host Microbe) Letters read on TWiV 1289 Timestamps by Jolene Ramsey. Thanks! Weekly Picks Angela – How hibernating bears maintain muscle mass Alan – The flood of Chinese grad students in the 2000s was a boon to US students. Vincent – Feynman Lectures on Physics Listener Picks David – Stewart Cheifet, Host of TV's 'Computer Chronicles,' Dies at 87 Charles – Last Year, and the Year to Come Intro music is by Ronald Jenkees Send your virology questions and comments to twiv@microbe.tv Content in this podcast should not be construed as medical advice.

Send us a textCould a simple blood test help identify chronic pulmonary hypertension when echo access is limited? This week on The Incubator Podcast, Ben and Daphna explore this question and others relevant to daily NICU practice. A Toronto study examines NT-proBNP as a practical diagnostic tool in extremely preterm infants.They also examine a puzzling finding from Italy and Belgium: despite near-universal antibiotic use in neonates with HIE undergoing cooling, actual culture-positive sepsis rates are surprisingly low. What does this mean for our approach to empiric antibiotics?Ben presents Norwegian data showing that serial physical exams cut antibiotic exposure in half for term and late preterm infants—without compromising safety. Daphna follows with research connecting NICU capacity strain to patient outcomes, underscoring why adequate staffing isn't just about comfort, but about survival.The episode concludes with Ben, Daphna, and Eli discussing the recent CDC changes to Hepatitis B birth dose recommendations. With federal guidance now diverging from AAP recommendations, how do we navigate conversations with families? They explore transmission risks parents may overlook and share approaches to shared decision-making when expert opinions conflict. A full week of neonatal medicine research and real-world clinical challenges, all in one episodeSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

Send us a textThis week on Neo News, we tackle the recent and controversial divergence between CDC and AAP guidelines regarding the birth dose of the Hepatitis B vaccine. With the CDC now recommending a deferred schedule for infants of Hepatitis B-negative mothers, we explore the clinical implications, the risks of vertical transmission, and the challenge of navigating discordant public health advice. We discuss how to handle shared decision-making in an era of waning vaccine confidence and why the "birth dose" remains a critical safety net in a community setting. Join us as we break down the data behind the headlines.----American Academy of Pediatrics. (2025, December 15). AAP: CDC decision on universal birth dose of hepatitis B vaccine irresponsible and purposely misleading. AAP News. https://publications.aap.org/aapnews/news/33980/AAP-CDC-decision-on-universal-birth-dose-of?searchresult=1?autologincheck=redirectedSupport the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

ICAN lead counsel Aaron Siri, esq., breaks down ACIP's historic decision to end the recommendation of universal Hepatitis B vaccination at birth for babies of healthy, Hep-B–negative mothers—moving it to age 2 months and “shared decision making.” He details major gaps in the safety data, evidence of harm buried in our federal injury programs, and an ethical crisis in the U.S. of pressuring parents to vaccinate their children under threat of CPS. Siri also contrasts U.S. policy with nations like mandate-free Denmark, which recommends far fewer vaccines while enjoying better health outcomes.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

A trip to get an updated tetanus shot led to the realization that Justin never got a Hepatitis B vaccine. So Dr. Sydnee explains what exactly is Hep B, the recent headlines surrounding the vaccine, why do people usually get this vaccine as babies – and why didn't Justin get it?Music: "Medicines" by The Taxpayers https://taxpayers.bandcamp.com/Harmony House: https://harmonyhousewv.com/

There have been quite a few developments recently on the vaccine front coming out of the U.S. Department of Health and Human Services. Health Secretary Robert F. Kennedy Jr.'s new vaccine advisory panel recommends delaying the first vaccine that's given to many children, the Hepatitis B vaccine that's administered pretty much as soon as they're born.President Donald Trump signed an executive memo, starting the process of aligning the U.S. childhood vaccine schedule with other developed nations.West Virginia is flip-flopping on the question of whether to allow religious exemptions for school vaccines.

Day one of this week's Advisory Committee on Immunization Practices (ACIP) meeting revealed a stunning shift in the hepatitis B debate. For the first time, panel experts openly acknowledged they do not have the data to justify giving every newborn a hepatitis B shot on their first day of life. Hear how this new advisory group challenged inflated risk assumptions, admitted the evidence for newborn safety is surprisingly weak, and questioned why infants are expected to bear the burden for failures in adult screening and prevention. This pivotal exchange is reshaping the national conversation around vaccine policy—and the science that must support it.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

On Friday, the Centers for Disease Control and Prevention's vaccine advisory panel voted to end a recommendation that all newborns be immunized at birth against hepatitis B. That guidance had been in place for more than 30 years. Hepatitis B is a highly infectious virus that can cause severe liver damage, including cirrhosis and cancer.The members of this panel, known as ACIP, were handpicked by Health and Human Services Secretary Robert F Kennedy Junior. That's after he abruptly fired all the previous 17 members of the panel earlier this year. That which led top officials at the CDC to resign in protest.His new members have publicly stated they want to revisit the entire childhood vaccine schedule. And after the panel's recent meeting, President Donald Trump expressed support for such a review.How will ending the recommended Hepatitis B shot for newborns affect public health? And what's next for childhood vaccinations?Find more of our programs online. Listen to 1A sponsor-free by signing up for 1A+ at plus.npr.org/the1a. Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

The Centers for Disease Control and Prevention is likely to reverse its long-standing recommendation that all newborns be immunized against Hepatitis B. We spoke with Demetre Daskalakis, the former director of the CDC's National Center for Immunization and Respiratory Diseases, about the long-term impact of the proposed changes, how parents should respond, and whether we should all worry about vaccine recommendations coming from this administration.And in headlines, the Supreme Court could greatly expand the presidential power over independent federal agencies, Paramount launches a hostile takeover bid to pry Warner Bros. Discovery from Netflix, and President Donald Trump saves American farmers from tariffs by using… tariffs?Show Notes: Call Congress – 202-224-3121Subscribe to the What A Day Newsletter – https://tinyurl.com/3kk4nyz8What A Day – YouTube – https://www.youtube.com/@whatadaypodcastFollow us on Instagram – https://www.instagram.com/crookedmedia/For a transcript of this episode, please visit crooked.com/whataday Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Hi. In today's episode of Even More News, Katy, Jonathan, and Cody discuss the impacts of the CDC's new recommendations on the Hepatitis B vaccine. Then they get into how FIFA created a peace prize just to award it to Trump, which, according to Fox, is evidence of the existence of God. They also cover Trump's fury over Henry Cuellar not becoming a Republican as a thank-you for Trump pardoning him for all the crimes he committed.As always, we recorded right before that big thing that happened.PATREON: https://patreon.com/somemorenewsMERCH: https://shop.somemorenews.comYOUTUBE MEMBERSHIP: https://www.youtube.com/channel/UCvlj0IzjSnNoduQF0l3VGng/join#CDC #HenryCuellar #evenmorenewsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Federal scrutiny of Minnesota's public programs intensifies as investigators uncover expansive fraud tied to the state's Somali community. A federal advisory panel votes to revise the Hepatitis B newborn vaccine schedule, igniting fierce backlash from legacy media and some former health officials. Netflix strikes a blockbuster deal to buy Warner Bros., a move poised to upend Hollywood and reshape the future of theatrical movies. President Trump publicly lashes out at Democratic Congressman Henry Cuellar just days after granting him and his wife full pardons.  Herald Group: Learn more at https://GuardYourCard.com Geviti: Go to https://gogeviti.com/megynand get 20% off with code MEGYN. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Sue Kressly, president of the American Academy of Pediatrics, joins Dr. Vin Gupta of Meidas Health for an emergency episode to discuss the recommended changes to the Hepatitis B vaccine schedule for babies. She clearly explains why the proposed test-and-immunize strategy would take us back decades to a time when tens of thousands of children were needlessly infected with a serious virus. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of “The Liz Wheeler Show,” Liz examines the FBI's claim to have found the January 6 pipe bomber to see if the evidence adds up. She also discusses the recent CDC schedule change regarding the Hepatitis B vaccine for newborns. SPONSORS: COZY EARTH: Head to http://www.CozyEarth.com and use my code “LIZ” for up to 40% off – just be sure to place your order by December12th for guaranteed Christmas delivery. ALL FAMILY PHARMACY: If you value preparation, clarity, and the freedom to make informed choices, visit http://www.AllFamilyPharmacy.com/LIZ before December second and secure your Black Friday BOGO deal. -- Get the full audio show on all major podcast platforms: Apple Podcasts: https://podcasts.apple.com/us/podcast/the-liz-wheeler-show/id1567701295 Spotify: https://open.spotify.com/show/4LhlHfocr5gMnLj4l573iI iHeart: https://www.iheart.com/podcast/269-the-liz-wheeler-show-82737301/ Subscribe to The Liz Wheeler Show newsletter: http://lizwheelernewsletter.com Get VIP access to The Liz Wheeler Show on Locals: https://lizwheeler.locals.com/. Stay in touch with Liz on social media: YouTube: https://www.youtube.com/@lizwheeler Facebook: https://www.facebook.com/OfficialLizWheeler Twitter: https://twitter.com/Liz_Wheeler Instagram: https://www.instagram.com/OfficialLizWheeler Rumble: https://rumble.com/LizWheeler Website: https://lizwheeler.com Learn more about your ad choices. Visit megaphone.fm/adchoices

In this special episode of the podcast, Dr. Osterholm and Chris Dall discuss the ACIP's recent decision to end universal hepatitis B birth dose recommendations and the impact it will have on public health. Noted articles: …And What Have We Done?This Is What It Looks Like When RFK Jr. WinsResources for vaccine and public health advocacy: Voices for Vaccines Families Fighting Flu Vaccinate Your Family Shot@Life Medical Reserve Corps Learn more about the Vaccine Integrity Project MORE EPISODES       SUPPORT THIS PODCAST

A CDC advisory panel has voted to roll back Hepatitis B vaccines for newborns. If approved, it could reverse 30 years of gains in fighting the liver disease. We also look how Hollywood is responding Netflix purchasing Warner Bros. And we look at a series of economic indicators and how the Federal Reserve might respond to in their meeting next week.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

On this, our 303rd Evolutionary Lens livestream, we discuss the recommendation to stop vaccinating newborns against Hepatitis B, as just handed down by ACIP (Advisory Committee on Immunization Practices) for the CDC. Why were newborns whose mothers do not have Hep B, being vaccinated against a disease that is contracted through sexual activity and dirty needles? We discuss claims of “safe and effective,” risk stratification, the childhood vaccine schedule, and what “individual-based decision-making” will mean for parents and doctors. Then, new research: tattoo ink induces inflammation in lymph nodes, and changes the immune response to vaccination. Finally: an homage to Tom Stoppard, playwright extraordinaire, author of Rosencrantz and Guildenstern are Dead, Arcadia, and so much more. RIP.*****Our sponsors:CrowdHealth: Pay for healthcare with crowdfunding instead of insurance. It's way better. Use code DarkHorse at http://JoinCrowdHealth.com to get 1st 3 months for $99/month.ARMRA: Colostrum is our first food and can help restore your health and resilience as an adult. Go to http://www.tryarmra.com/DARKHORSE to get 15% off your first order.Helix: Excellent, sleep-enhancing, American-made mattresses. Go to http://www.HelixSleep.com/DarkHorse to get 27% sitewide.*****Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.com/Heather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.comOur book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned)Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org*****Mentioned in this episode:ACIP Hep B recommendation: https://www.cdc.gov/media/releases/2025/2025-acip-recommends-individual-based-decision-making-for-hepatitis-b-vaccine-for-infants-born-to-women.htmlRetsef Levi on Hep B rec: https://x.com/cdcgov/status/1996967080793358366RFK on vaccines: https://x.com/seckennedy/status/1997104582128754854Capucetti et al 2025. Tattoo ink induces inflammation in the draining lymph node and alters the immune response to vaccination. Proceedings of the National Academy of Sciences, 122(48), p.e2510392122: https://www.pnas.org/doi/pdf/10.1073/pnas.2510392122Support the show